Showing results (91-100 of 143) with videos related to
Sort By:
Pageof 15
Journal of Medicinal Chemistry|November 14, 2014
Binding mode and potency of N-indolyloxopyridinyl-4-aminopropanyl-based inhibitors targeting Trypanosoma cruzi CYP51Debora F Vieira, Jun Yong Choi, Claudia M Calvet, et al.Bioorganic & Medicinal Chemistry Letters|February 15, 2011
Synthesis and SAR of novel quinazolines as potent and brain-penetrant c-jun N-terminal kinase (JNK) inhibitorsYuanjun He, Theodore M Kamenecka, Youseung Shin, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 9, 2019
Promoting activity of (α4)3(β2)2 nicotinic cholinergic receptors reduces ethanol consumptionJingyi Wang, Angelo Blasio, Holly L Chapman, et al.Emerging Microbes & Infections|November 30, 2025
Combining spironolactone to antiretroviral therapy accelerates HIV decay in humanized miceLijun Ling, Luisa P Mori, Andrew Soper, et al.Bioorganic & Medicinal Chemistry Letters|February 20, 2010
The development of benzimidazoles as selective rho kinase inhibitorsE Hampton Sessions, Michael Smolinski, Bo Wang, et al.ACS Chemical Neuroscience|June 14, 2011
Small Molecule c-jun-N-terminal Kinase (JNK) Inhibitors Protect Dopaminergic Neurons in a Model of Parkinson's DiseaseJeremy W Chambers, Alok Pachori, Shannon Howard, et al.Neurobiology of Learning and Memory|November 23, 2023
Basolateral amygdala corticotropin releasing factor receptor 2 interacts with nonmuscle myosin II to destabilize memory in malesMadalyn Hafenbreidel, Surya Pandey, Sherri B Briggs, et al.Journal of Medicinal Chemistry|December 2, 2009
Synthesis, biological evaluation, X-ray structure, and pharmacokinetics of aminopyrimidine c-jun-N-terminal kinase (JNK) inhibitorsTed Kamenecka, Rong Jiang, Xinyi Song, et al.Biorxiv : the Preprint Server for Biology|May 18, 2026
Pharmacological rescue of mitochondrial dysfunction, neurite degeneration, and premature death of ALS and AD iPSC-derived neuronsNeelam Shahani, Rupkatha Banerjee, Courtney MacMullen, et al.Journal of the American Chemical Society|August 13, 2021
Reprogramming of Protein-Targeted Small-Molecule Medicines to RNA by Ribonuclease RecruitmentPeiyuan Zhang, Xiaohui Liu, Daniel Abegg, et al.Pageof 15